Pricing

Synklino

0 followers

‌

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.

Industries

Biotechnology, Health Care

Headquarters

Lyngby, Denmark

Employees

11-50

Links

Org chart

Thomas Kledal

CEO & Co-Founder

Thomas Kledal

Collapse

Mads Jeppesen

CMC Project Director & Co-Founder

Jette Wagtberg Sen

COO

Carit Jacques Andersen

CFO

Josefin-Beate Holz

CMO

Josi Holz

Senior Strategic Advisor

Mads Gravers Jeppesen

Head of Discovery

Mette M Rosenkilde

Member of the Board of Directors & Co-Founder

Søren Neve

Head of Pharmacology

Teams

Board of Directors

11 members

Leadership Team

7 members

Scientific Team

4 members

Advisory Team

4 members

Similar companies

Ascendis Pharma

8 followers

Amazentis

1 follower

Tessera Therapeutics

2 followers

Merck

211 followers

Eupry

4 followers

Pyxis Oncology

1 follower

Mineralys Therapeutics

1 follower

Fitpage

1 follower

Thermo Fisher Scientific

155 followers

Biogen

114 followers

Apollo Global Management

36 followers

Explore companies